Pharma-Bio Serv, Inc. (PBSV)

Revenue by Product

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017
Puerto Rico Consulting	5.69M
Puerto Rico Consulting Growth	-29.21%
United States Consulting	3.16M
United States Consulting Growth	-32.32%
Europe Consulting	571.18K
Europe Consulting Growth	-86.59%
Other	85.78K
Other Growth	1275.99%

Revenue by Geography

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019	Oct 31, 2018	Oct 31, 2017
Puerto Rico	5.69M
Puerto Rico Growth	-29.21%
United States	3.16M
United States Growth	-32.32%
Europe	571.18K
Europe Growth	-86.59%
Other	85.78K
Other Growth	1275.99%